Announcement • Jan 24
Regenera Insights Inc. Announces Board Changes Regenera Insights Inc. announced that Mr. Steve Olasz has tendered his resignation as director of Regenera. Mr. Olasz served on the board of directors of the Corporation since 2025. Mr. Douglas Whitehead has accepted the appointment as independent director to the board of the Corporation. Mr. Whitehead, an accomplished Project Developer and Business Manager, leads and manages diverse projects across various spheres of business within a prominent group of companies. As a Project Manager Professional (PMP) Mr. Whitehead has over 17 years of experience in Project and Business Management, focusing on Project Planning and Execution. Announcement • Sep 26
Regenera Insights Inc. announced that it has received CAD 0.236192 million in funding On September 25, 2025, Regenera Insights Inc closed the transaction. Prior to the closing of the private placement, the company had 115,073,100 common shares and 40,625,000 warrants issued and outstanding and post closing, now has 126,882,712 common shares and 52,434,612 warrants issued and outstanding. Announcement • Sep 19
Regenera Insights Inc. announced that it expects to receive CAD 0.236192 million in funding Regenera Insights Inc. has announced a non-brokered private placement on September 18, 2025. The company will issue 11,809,612 units at a price of CAD 0.02 for gross proceeds of CAD 236,192.24 to the director of the company. Each unit will consist of one common share and one common share purchase warrant. Each warrant will entitle the holder to purchase one common share of Regeneraat an exercise price of CAD 0.05 per warrant share for a period of five years after the date of issuance. The director currently owns or controls, directly or indirectly, 2,337,496 common shares (2.03 per cent). Post closing of the private placement, he will own or control, directly or indirectly, 14,148,108 common shares (11.15 per cent) on an undiluted basis and, on a fully diluted basis, will own or control, directly or indirectly, 16.98 per cent of the common shares of Regenera. The common shares and warrants to be issued, pursuant to the private placement, will be subject to a regulatory hold period of four months and one day from the date of the Unit issuance. 
